70 related articles for article (PubMed ID: 21533382)
1. Monoclonal antibodies directed against the EGF receptor show differential bindings of amphiregulin and EGF to the EGF receptor.
Modjtahedi H; Cohen B; Dean C
Int J Oncol; 1997 Feb; 10(2):339-47. PubMed ID: 21533382
[TBL] [Abstract][Full Text] [Related]
2. Anti-EGFR monoclonal antibodies which act as EGF, TGF alpha, HB-EGF and BTC antagonists block the binding of epiregulin to EGFR-expressing tumours.
Modjtahedi H; Komurasaki T; Toyoda H; Dean C
Int J Cancer; 1998 Jan; 75(2):310-6. PubMed ID: 9462724
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies to the EGF receptor act as betacellulin antagonists.
Modjtahedi H; Dean C
Biochem Biophys Res Commun; 1996 Apr; 221(3):625-30. PubMed ID: 8630011
[TBL] [Abstract][Full Text] [Related]
4. Antibody-induced inhibition of growth of egfr overexpressing tumors occurs in the absence of receptor down-regulation.
Modjtahedi H; Dean C
Int J Oncol; 1995 Oct; 7(4):783-8. PubMed ID: 21552904
[TBL] [Abstract][Full Text] [Related]
5. EGFR blockade by tyrosine kinase inhibitor or monoclonal antibody inhibits growth, directs terminal differentiation and induces apoptosis in the human squamous cell carcinoma HN5.
Modjtahedi H; Affleck K; Stubberfield C; Dean C
Int J Oncol; 1998 Aug; 13(2):335-42. PubMed ID: 9664130
[TBL] [Abstract][Full Text] [Related]
6. The binding of HB-EGF to tumour cells is blocked by mAbs which act as EGF and TGF alpha antagonists.
Modjtahedi H; Dean C
Biochem Biophys Res Commun; 1995 Feb; 207(1):389-97. PubMed ID: 7857293
[TBL] [Abstract][Full Text] [Related]
7. Retinoid-induced epidermal hyperplasia is mediated by epidermal growth factor receptor activation via specific induction of its ligands heparin-binding EGF and amphiregulin in human skin in vivo.
Rittié L; Varani J; Kang S; Voorhees JJ; Fisher GJ
J Invest Dermatol; 2006 Apr; 126(4):732-9. PubMed ID: 16470170
[TBL] [Abstract][Full Text] [Related]
8. The human EGF receptor as a target for cancer therapy: six new rat mAbs against the receptor on the breast carcinoma MDA-MB 468.
Modjtahedi H; Styles JM; Dean CJ
Br J Cancer; 1993 Feb; 67(2):247-53. PubMed ID: 8094290
[TBL] [Abstract][Full Text] [Related]
9. Co-expression of heparin-binding EGF-like growth factor and related peptides in human gastric carcinoma.
Naef M; Yokoyama M; Friess H; Büchler MW; Korc M
Int J Cancer; 1996 May; 66(3):315-21. PubMed ID: 8621250
[TBL] [Abstract][Full Text] [Related]
10. Targeting of cells expressing wild-type EGFR and type-III mutant EGFR (EGFRvIII) by anti-EGFR MAb ICR62: a two-pronged attack for tumour therapy.
Modjtahedi H; Moscatello DK; Box G; Green M; Shotton C; Lamb DJ; Reynolds LJ; Wong AJ; Dean C; Thomas H; Eccles S
Int J Cancer; 2003 Jun; 105(2):273-80. PubMed ID: 12673691
[TBL] [Abstract][Full Text] [Related]
11. Autocrine action of amphiregulin in a colon carcinoma cell line and immunocytochemical localization of amphiregulin in human colon.
Johnson GR; Saeki T; Gordon AW; Shoyab M; Salomon DS; Stromberg K
J Cell Biol; 1992 Aug; 118(3):741-51. PubMed ID: 1639855
[TBL] [Abstract][Full Text] [Related]
12. Effects of different ligands on epidermal growth factor receptor (EGFR) nuclear translocation.
Faria JAQA; de Andrade C; Goes AM; Rodrigues MA; Gomes DA
Biochem Biophys Res Commun; 2016 Sep; 478(1):39-45. PubMed ID: 27462018
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy of human tumour xenografts overexpressing the EGF receptor with rat antibodies that block growth factor-receptor interaction.
Modjtahedi H; Eccles S; Box G; Styles J; Dean C
Br J Cancer; 1993 Feb; 67(2):254-61. PubMed ID: 7679281
[TBL] [Abstract][Full Text] [Related]
14. The growth-response of human tumor-cell lines expressing the EGF receptor to treatment with EGF and or mabs that block ligand-binding.
Modjtahedi H; Styles J; Dean C
Int J Oncol; 1993 Aug; 3(2):237-43. PubMed ID: 21573354
[TBL] [Abstract][Full Text] [Related]
15. Expressions of epidermal growth factor family and its receptor in hepatocellular carcinoma cell lines: relationship to cell proliferation.
Hisaka T; Yano H; Haramaki M; Utsunomiya I; Kojiro M
Int J Oncol; 1999 Mar; 14(3):453-60. PubMed ID: 10024677
[TBL] [Abstract][Full Text] [Related]
16. Betacellulin and amphiregulin induce upregulation of cyclin D1 and DNA synthesis activity through differential signaling pathways in vascular smooth muscle cells.
Shin HS; Lee HJ; Nishida M; Lee MS; Tamura R; Yamashita S; Matsuzawa Y; Lee IK; Koh GY
Circ Res; 2003 Aug; 93(4):302-10. PubMed ID: 12869389
[TBL] [Abstract][Full Text] [Related]
17. Involvement of epidermal growth factor receptor in chemically induced mouse bladder tumour progression.
el-Marjou A; Delouvée A; Thiery JP; Radvanyi F
Carcinogenesis; 2000 Dec; 21(12):2211-8. PubMed ID: 11133810
[TBL] [Abstract][Full Text] [Related]
18. The ErbB/HER family of protein-tyrosine kinases and cancer.
Roskoski R
Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
[TBL] [Abstract][Full Text] [Related]
19. Altered EGFR localization and degradation in human breast cancer cells with an amphiregulin/EGFR autocrine loop.
Willmarth NE; Baillo A; Dziubinski ML; Wilson K; Riese DJ; Ethier SP
Cell Signal; 2009 Feb; 21(2):212-9. PubMed ID: 18951974
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.
O-charoenrat P; Modjtahedi H; Rhys-Evans P; Court WJ; Box GM; Eccles SA
Cancer Res; 2000 Feb; 60(4):1121-8. PubMed ID: 10706134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]